Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Chaigne-Delalande

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Trends in Immunology|June 17, 2014
Divalent cation signaling in immune cellsBenjamin Chaigne-Delalande, Michael J Lenardo
Current Opinion in Pediatrics|October 15, 2014
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defectJuan Ravell, Benjamin Chaigne-Delalande, Michael Lenardo
Archivum Immunologiae Et Therapiae Experimentalis|February 6, 2008
Rewinding the DISCBenjamin Chaigne-Delalande, Jean-François Moreau, Patrick Legembre
Autophagy|February 18, 2009
An atypical necrotic signal induced by immunosuppressive and anti-viral agentsBenjamin Chaigne-Delalande, Gwendalline Guidicelli, Lionel Couzi, et al.
Magnesium Research|October 11, 2011
Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiencyFeng-Yen Li, Michael J Lenardo, Benjamin Chaigne-Delalande
Plos One|November 1, 2018
CytoBinning: Immunological insights from multi-dimensional dataYang Shen, Benjamin Chaigne-Delalande, Richard W J Lee, et al.
Plos One|September 28, 2011
Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell deathR Anthony Barnitz, Benjamin Chaigne-Delalande, Diane L Bolton, et al.
Virology Journal|May 17, 2011
Human immunodeficiency virus type 1 Vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrestKeiko Sakai, R Anthony Barnitz, Benjamin Chaigne-Delalande, et al.
Endocrinology|September 10, 2003
Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-IILaurence Duplomb, Benjamin Chaigne-Delalande, Patricia Vusio, et al.
Blood|February 20, 2014
XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virusFeng-Yen Li, Benjamin Chaigne-Delalande, Helen Su, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Trends in Immunology|June 17, 2014
Divalent cation signaling in immune cellsBenjamin Chaigne-Delalande, Michael J Lenardo
Current Opinion in Pediatrics|October 15, 2014
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defectJuan Ravell, Benjamin Chaigne-Delalande, Michael Lenardo
Archivum Immunologiae Et Therapiae Experimentalis|February 6, 2008
Rewinding the DISCBenjamin Chaigne-Delalande, Jean-François Moreau, Patrick Legembre
Autophagy|February 18, 2009
An atypical necrotic signal induced by immunosuppressive and anti-viral agentsBenjamin Chaigne-Delalande, Gwendalline Guidicelli, Lionel Couzi, et al.
Magnesium Research|October 11, 2011
Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiencyFeng-Yen Li, Michael J Lenardo, Benjamin Chaigne-Delalande
Plos One|November 1, 2018
CytoBinning: Immunological insights from multi-dimensional dataYang Shen, Benjamin Chaigne-Delalande, Richard W J Lee, et al.
Plos One|September 28, 2011
Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell deathR Anthony Barnitz, Benjamin Chaigne-Delalande, Diane L Bolton, et al.
Virology Journal|May 17, 2011
Human immunodeficiency virus type 1 Vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrestKeiko Sakai, R Anthony Barnitz, Benjamin Chaigne-Delalande, et al.
Endocrinology|September 10, 2003
Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-IILaurence Duplomb, Benjamin Chaigne-Delalande, Patricia Vusio, et al.
Blood|February 20, 2014
XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virusFeng-Yen Li, Benjamin Chaigne-Delalande, Helen Su, et al.
Pageof 3